Evidence map›Paper›PMID 35740991›Full record

ArticleCells2022

Neural Differentiation Potential of Mesenchymal Stem Cells Enhanced by Biocompatible Chitosan-Gold Nanocomposites.

Huey-Shan Hung, Yi-Chin Yang, Chih-Hsuan Chang, Kai-Bo Chang, Chiung-Chyi Shen, Chien-Lun Tang, Szu-Yuan Liu, Chung-Hsin Lee, Chun-Ming Yen, Meng-Yin Yang

Open access · goldAbstract read
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Huey-Shan HungGraduate Institute of Biomedical Science, China Medical University, Taichung 40402, Taiwan.ORCID 0000-0003-4161-2428
Yi-Chin YangDepartment of Neurosurgery, Neurological Institute, Taichung Veterans General Hospital, Taichung 407204, Taiwan.ORCID 0000-0002-9651-3761
Chih-Hsuan ChangGraduate Institute of Biomedical Science, China Medical University, Taichung 40402, Taiwan.
Kai-Bo ChangGraduate Institute of Biomedical Science, China Medical University, Taichung 40402, Taiwan.
Chiung-Chyi ShenDepartment of Neurosurgery, Neurological Institute, Taichung Veterans General Hospital, Taichung 407204, Taiwan.
Chien-Lun TangDepartment of Neurosurgery, Neurological Institute, Taichung Veterans General Hospital, Taichung 407204, Taiwan.
Szu-Yuan LiuDepartment of Neurosurgery, Neurological Institute, Taichung Veterans General Hospital, Taichung 407204, Taiwan.
Chung-Hsin LeeDepartment of Neurosurgery, Neurological Institute, Taichung Veterans General Hospital, Taichung 407204, Taiwan.
Chun-Ming YenDepartment of Neurosurgery, Neurological Institute, Taichung Veterans General Hospital, Taichung 407204, Taiwan.
Meng-Yin YangDepartment of Neurosurgery, Neurological Institute, Taichung Veterans General Hospital, Taichung 407204, Taiwan.
Taichung Veterans General Hospital · TWChina Medical University · TWNational Chung Hsing University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chitosan (Chi) is a natural polymer that has been demonstrated to have potential as a promoter of neural regeneration. In this study, Chi was prepared with various amounts (25, 50, and 100 ppm) of gold (Au) nanoparticles for use in in vitro and in vivo assessments. Each as-prepared material was first characterized by UV-visible spectroscopy (UV-Vis), Fourier-transform infrared spectroscopy (FTIR), atomic force microscopy (AFM), scanning electron microscopy (SEM), and Dynamic Light Scattering (DLS). Through the in vitro experiments, Chi combined with 50 ppm of Au nanoparticles demonstrated better biocompatibility. The platelet activation, monocyte conversion, and intracellular ROS generation was remarkably decreased by Chi-Au 50 pm treatment. Furthermore, Chi-Au 50 ppm could facilitate colony formation and strengthen matrix metalloproteinase (MMP) activation in mesenchymal stem cells (MSCs). The lower expression of CD44 in Chi-Au 50 ppm treatment demonstrated that the nanocomposites could enhance the MSCs undergoing differentiation. Chi-Au 50 ppm was discovered to significantly induce the expression of GFAP, β-Tubulin, and nestin protein in MSCs for neural differentiation, which was verified by real-time PCR analysis and immunostaining assays. Additionally, a rat model involving subcutaneous implantation was used to evaluate the superior anti-inflammatory and endothelialization abilities of a Chi-Au 50 ppm treatment. Capsule formation and collagen deposition were decreased. The CD86 expression (M1 macrophage polarization) and leukocyte filtration (CD45) were remarkably reduced as well. In summary, a Chi polymer combined with 50 ppm of Au nanoparticles was proven to enhance the neural differentiation of MSCs and showed potential as a biosafe nanomaterial for neural tissue engineering.

Indexed as

ChitosanMesenchymal Stem CellsMetal NanoparticlesNanocompositesAnimalsGoldRatsChitosanGoldchitosangold nanoparticlesmesenchymal stem cellneural differentiationtissue engineering

Identifiers

PMID35740991
PMCPMC9221394
OpenAlexW4281627246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.